Evidence map›Paper›PMID 28686858›Full record

ArticleAmerican journal of human genetics2017

A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia.

Ana I Seixas, Joana R Loureiro, Cristina Costa, Andrés Ordóñez-Ugalde, Hugo Marcelino, Cláudia L Oliveira, José L Loureiro, Ashutosh Dhingra, Eva Brandão, Vitor T Cruz and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. A genome-wide approach for the discovery of novel repeat expansion disorders in the Undiagnosed Diseases Network cohort.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  14. Movement Disorders in Hereditary Cerebellar Ataxia.Movement disorders clinical practice · 2025
    Article
  15. Article
  16. Novel, complex configurations of theBrain communications · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 4 countries.

Ana I SeixasUnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal.
Joana R LoureiroInstitute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal.
Cristina CostaDepartment of Neurology, Hospital Prof. Doutor Fernando Fonseca EPE, 2720-276 Amadora, Portugal.
Andrés Ordóñez-UgaldeInstitute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Instituto de Investigación Sanitaria and Fundación Pública Galega de Medicina Xenómica, Centro para Investigación Biomédica en Red de Enfermedades Raras, 15706 Santiago de Compostela, Spain.
Hugo MarcelinoInstitute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Vertebrate Development and Regeneration Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Cláudia L OliveiraInstitute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
José L LoureiroUnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Department of Neurology, Hospital São Sebastião, 4520-211 Feira, Portugal.
Ashutosh DhingraGerman Center for Neurodegenerative Diseases, 72076 Tübingen, Germany.
Eva BrandãoDepartment of Neurology, Hospital São Sebastião, 4520-211 Feira, Portugal.
Vitor T CruzDepartment of Neurology, Hospital São Sebastião, 4520-211 Feira, Portugal.
Angela TimóteoDepartment of Neurology, Hospital Prof. Doutor Fernando Fonseca EPE, 2720-276 Amadora, Portugal.
Beatriz QuintánsInstituto de Investigación Sanitaria and Fundación Pública Galega de Medicina Xenómica, Centro para Investigación Biomédica en Red de Enfermedades Raras, 15706 Santiago de Compostela, Spain.
Guy A RouleauMontreal Neurological Institute and Department of Neurology and Neurosurgery, McGill University, Montréal, QC H3A 2B4, Canada.
Patrizia RizzuGerman Center for Neurodegenerative Diseases, 72076 Tübingen, Germany.
Ángel CarracedoInstituto de Investigación Sanitaria and Fundación Pública Galega de Medicina Xenómica, Centro para Investigación Biomédica en Red de Enfermedades Raras, 15706 Santiago de Compostela, Spain.
José BessaInstitute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Vertebrate Development and Regeneration Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Peter HeutinkGerman Center for Neurodegenerative Diseases, 72076 Tübingen, Germany.
Jorge SequeirosUnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal.
Maria J SobridoInstituto de Investigación Sanitaria and Fundación Pública Galega de Medicina Xenómica, Centro para Investigación Biomédica en Red de Enfermedades Raras, 15706 Santiago de Compostela, Spain.
Paula CoutinhoUnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal.
Isabel SilveiraInstitute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal. Electronic address: isilveir@ibmc.up.pt.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTUniversidade do Porto · PTFundación Pública Galega de Medicina Xenómica · ESGerman Center for Neurodegenerative Diseases · DEHospital de São Sebastião · PTHospital Prof. Dr. Fernando Fonseca · PTMontreal Neurological Institute and Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in human genetics in recent years have largely been driven by next-generation sequencing (NGS); however, the discovery of disease-related gene mutations has been biased toward the exome because the large and very repetitive regions that characterize the non-coding genome remain difficult to reach by that technology. For autosomal-dominant spinocerebellar ataxias (SCAs), 28 genes have been identified, but only five SCAs originate from non-coding mutations. Over half of SCA-affected families, however, remain without a genetic diagnosis. We used genome-wide linkage analysis, NGS, and repeat analysis to identify an (ATTTC)

Indexed as

Genetic Predisposition to DiseasePhysical Chromosome MappingAdaptor Proteins, Signal TransducingAdolescentAdultAge of OnsetAllelesBase SequenceCerebellumChromosome SegregationChromosomes, Human, Pair 1DNA, IntergenicDNA Mutational AnalysisEmbryonic DevelopmentFemaleHaplotypesAdaptor Proteins, Signal TransducingDAB1 protein, humanDNA, IntergenicNerve Tissue ProteinsReelin ProteinRELN protein, humanRNARNA, MessengerDAB1 reelin adaptor proteinlarge Alu pentanucleotide repeatneurodegenerationneurodegenerative diseaseneurodevelopmental generepeat expansionrepeat instabilityRNA-mediated toxicitySCA37unstable repeat insertion

Identifiers

PMID28686858
PMCPMC5501871
OpenAlexW2733719426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.